These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. Wang C; Cao S; Yan Y; Ying Q; Jiang T; Xu K; Wu A BMC Cancer; 2010 Aug; 10():415. PubMed ID: 20696081 [TBL] [Abstract][Full Text] [Related]
9. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381 [TBL] [Abstract][Full Text] [Related]
10. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. Saikali S; Avril T; Collet B; Hamlat A; Bansard JY; Drenou B; Guegan Y; Quillien V J Neurooncol; 2007 Jan; 81(2):139-48. PubMed ID: 17004103 [TBL] [Abstract][Full Text] [Related]
11. Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro. Wang LH; Ni CW; Lin YZ; Yin L; Jiang CB; Lv CT; Le Y; Lang Y; Zhao CY; Yang K; Jiao BH; Yin J Tumour Biol; 2014 Feb; 35(2):1157-68. PubMed ID: 24272336 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma. Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370 [TBL] [Abstract][Full Text] [Related]
13. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Al-Mayhani MT; Grenfell R; Narita M; Piccirillo S; Kenney-Herbert E; Fawcett JW; Collins VP; Ichimura K; Watts C Neuro Oncol; 2011 Aug; 13(8):830-45. PubMed ID: 21798846 [TBL] [Abstract][Full Text] [Related]
14. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme. Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895 [TBL] [Abstract][Full Text] [Related]
16. Heparanase expression of glioma in human and animal models. Hong X; Nelson KK; deCarvalho AC; Kalkanis SN J Neurosurg; 2010 Aug; 113(2):261-9. PubMed ID: 19835469 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507 [TBL] [Abstract][Full Text] [Related]